scholarly journals FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801

BMC Cancer ◽  
2013 ◽  
Vol 13 (1) ◽  
Author(s):  
Fuminori Yamaguchi ◽  
Yuko Hirata ◽  
Hossain Akram ◽  
Kazuyo Kamitori ◽  
Youyi Dong ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Mk 801 ◽  
Glutamate Antagonist

Evaluation of the glutamate antagonist dizocilipine maleate (MK-801) on neurologic outcome in a canine model of complete cerebral ischemia: correlation with hippocampal histopathology

1989 ◽  
Vol 481 (2) ◽  
pp. 228-234 ◽  
Author(s):  
John D. Michenfelder ◽  
William L. Lanier ◽  
Bernd W. Scheithauer ◽  
William J. Perkins ◽  
Gary T. Shearman ◽  
...  
Keyword(s):  
Cerebral Ischemia ◽  
Canine Model ◽  
Neurologic Outcome ◽  
Mk 801 ◽  
Glutamate Antagonist ◽  
Complete Cerebral Ischemia

The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat

1988 ◽  
Vol 24 (4) ◽  
pp. 543-551 ◽  
Author(s):  
C. K. Park ◽  
D. G. Nehls ◽  
D. I. Graham ◽  
G. M. Teasdale ◽  
J. McCulloch
Keyword(s):  
Brain Damage ◽  
Ischemic Brain Damage ◽  
Ischemic Brain ◽  
Mk 801 ◽  
Glutamate Antagonist

Multimodality treatment of hepatocellular carcinoma

1998 ◽  
Vol 13 (11-s4) ◽  
pp. S315-S319 ◽  
Author(s):  
ZHAO-YOU TANG ◽  
XIN-DA ZHOU ◽  
ZENG-CHEN MA ◽  
ZHI-QUAN WU ◽  
JIA FAN ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Multimodality Treatment

Hepatocellular carcinoma

1982 ◽  
Vol 118 (1) ◽  
pp. 69-70 ◽  
Author(s):  
A. J. Bennett
Keyword(s):  
Hepatocellular Carcinoma
Sign in / Sign up

Export Citation Format

Share Document